Dr. Reddy’s re-appoints G V Prasad as Co-Chairman and Managing Director
Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation
Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation
The decision to advance subcutaneous and oral amycretin into phase 3 is based on feedback received from regulatory authorities
Dilip Shanghvi to continue as the Executive Chairman of the Board
Padmanabhan brings over two decades of extensive experience in FMCG sector
Krishna Institute of Medical Sciences Ltd enters into agreement with Splendid Hospitals
This innovative formulation combines cutting-edge ingredients is a first of its kind in India to have a Duo-Lipo technology
Consequent to this appointment, Sarosh Shetty ceases to be Interim CEO of ICH.
Medanta is expected to incur a project capex of ~Rs. 600 crores in next 3-4 years
The study highlighted substantial improvements in key clinical parameters among RA patients who underwent AWS intervention
Subscribe To Our Newsletter & Stay Updated